Recovery & Rehabilitation

Clinical Context

Rehabilitation is one of the largest and fastest growing needs in global healthcare. The World Health Organization estimates that approximately 2.4 billion people worldwide are living with a health condition that may benefit from rehabilitation, and that need is expected to increase as populations age and chronic disease burden rises.

In the United States, chronic pain remains a major driver of disability, reduced mobility, and healthcare utilization. CDC data reported that 20.9% of U.S. adults experienced chronic pain in 2021, with high impact chronic pain affecting a meaningful subset of adults and interfering with daily activities.

Electrome's Recovery & Rehabilitation program is focused on areas where bioelectric therapy may fit naturally into existing care pathways:

• physical therapy and rehabilitation
• orthopedic recovery
• sports medicine
• chronic musculoskeletal pain
• postoperative recovery
• home based recovery
• non-opioid pain management
• connected recovery engagement

Why Recovery Needs New Infrastructure

Traditional recovery pathways often depend on a fragmented mix of in person therapy, medication, home exercises, patient adherence, and follow up visits. That model creates predictable gaps:

• patients may not adhere to recovery plans
• pain can limit mobility and participation
• medication side effects may reduce tolerability
• recovery data often remains invisible between visits
• providers may lack scalable tools for at home support

"Rehabilitation is not a single encounter, it is a process that unfolds over days, weeks, and months. Our opportunity is to build bioelectric recovery systems that fit into that process, at home, in clinics, and across connected care pathways."

A Continuous, Connected, Personalized Model

Electrome's long term thesis is that recovery infrastructure should become more continuous, connected, and personalized. That means combining wearable therapeutics, provider guided protocols, patient education, recovery engagement, outcomes tracking, AI assisted support, and clinical evidence generation into a single recovery pathway.

Bioelectric Therapy in Rehabilitation

Pulsed Shortwave Therapy (PSWT) uses pulsed electromagnetic fields rather than direct conductive electrical stimulation.

RecoveryRx^® is listed by FDA under 510(k) K190251 as a shortwave diathermy device for use other than applying therapeutic deep heat. The FDA 510(k) summary describes RecoveryRx as a pulsed shortwave therapy device using low voltage electronics.

Within recovery and rehabilitation settings, PSWT is relevant because wearable systems may support prolonged use models, low burden therapy application, at home recovery workflows, adjunctive recovery support, and integration with provider directed care.

Published shortwave therapy literature includes studies in musculoskeletal pain and knee osteoarthritis. A 2017 systematic review and meta analysis concluded that short wave therapy was beneficial for relieving pain caused by knee osteoarthritis, while also noting that pulsed modality appeared superior to continuous modality in the analyzed studies.

A separate review of short wave diathermy in musculoskeletal disorders concluded that short wave diathermy may be effective for reducing musculoskeletal pain in the short term, while also emphasizing the need to consider study quality, treatment parameters, and clinical context.

Rehabilitation Pathways

Electrome's Recovery & Rehabilitation program is designed for multiple deployment environments.

Physical Therapy. Bioelectric recovery tools may be positioned as an adjunct to exercise, mobility training, and therapist guided rehabilitation.

Orthopedics. Recovery workflows may include musculoskeletal pain, joint recovery, soft tissue recovery, and postoperative support.

Sports Medicine. Wearable recovery systems may support athletes and active adults managing pain, inflammation, and recovery load.

Home Recovery. Long duration wearable systems may help extend recovery support beyond the clinic visit.

Provider Programs. Provider facing workflows may include ordering, patient education, adherence support, and outcomes tracking.

"Recovery happens in motion, not only inside a clinic. Bioelectric therapy is compelling because it can potentially support recovery workflows in a way that is wearable, non-invasive, and compatible with modern rehabilitation pathways."

Commercial Deployment

Recovery & Rehabilitation is a commercial and platform program connected to Electrome's FDA-cleared pain and recovery infrastructure. The deployment model includes:

• ActiPatch^® consumer recovery products
• RecoveryRx^® clinical workflows
• provider ordering pathways
• retailer education
• rehabilitation and physical therapy channels
• future digital engagement tools

Near-Term Focus, Long-Term Vision

The near term commercial focus remains practical. Make FDA-cleared bioelectric recovery technology easier for patients, providers, and partners to access and use.

The longer term platform vision is broader. Integrate recovery devices, clinical evidence, digital engagement, and outcomes intelligence into a programmable bioelectric medicine infrastructure layer.

Evidence-Aware Positioning

Electrome avoids presenting recovery and rehabilitation as a solved clinical category. The literature around shortwave, pulsed shortwave, and electromagnetic therapy varies by indication, treatment parameters, device design, study population, comparator, endpoint, and exposure duration.

For that reason, the website consistently distinguishes FDA-cleared device status, published clinical evidence, commercial use cases, exploratory pipeline initiatives, and future platform capabilities. This discipline strengthens credibility with providers, regulators, investors, and institutional partners.